Methods of Treating Neurodevelopmental Diseases and Disorders
AssigneesDeakin University, The Florey Institute of Neuroscience and Mental Health
InventorsSteve CHEUNG, Wah Chin BOON
Life of this patent
Estimating the term…
Abstract
The present invention relates generally to methods for the treatment and/or prophylaxis of neurological diseases and disorders involving administration of trans 10-HDA. In particular, the methods of the present invention are useful in the treatment and/or prophylaxis of acquired or progressive neurodevelopmental disorders and conditions in mammals. More particularly, methods are taught herein for the treatment and/or prophylaxis of diseases and disorders such as autism spectrum disorders.
Claims13
A method for the treatment and/or prophylaxis of a disease or disorder of the central nervous system, comprising administering to a mammal in need thereof an effective amount of trans 10-hydroxy-2-decenoic acid or a pharmaceutically acceptable salt thereof, wherein the trans 10-hydroxy-2-decenoic acid or a pharmaceutically acceptable salt thereof is administered in a dosage in the range of 0.01 to 6000 mg/day.
-19. (canceled)
A composition comprising trans 10-hydroxy-2-decenoic acid or a pharmaceutically acceptable salt thereof for the treatment and/or prophylaxis of a neurodevelopmental disease or disorder, wherein the trans 10-hydroxy-2-decenoic acid or a pharmaceutically acceptable salt thereof is administered in a dosage in the range of 0.01 to 6000 mg/day.
A therapeutic agent for use in the treatment and/or prophylaxis of a neurodevelopmental disease or disorder, wherein the agent is trans 10-hydroxy-2-decenoic acid or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.